Filing Details

Accession Number:
0001567619-18-008134
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-17 17:07:24
Reporting Period:
2018-12-13
Accepted Time:
2018-12-17 17:07:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO Pharmaceutical Preparations (2834) 462996673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612217 Z. Avi Naider C/O Loxo Oncology, Inc.
One Landmark Square, Suite 1122
Stamford CT 06901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-13 725 $138.92 126,843 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct